AstraZeneca makes surprise U-turn with £300m pharma investment

AstraZeneca has reversed its decision to pause large-scale UK projects, pledging a £300m investment in the country after previously citing dissatisfaction with the NHS and drug pricing. The announcement, made by Keir Starmer, marks a surprise shift in the company's stance on the UK business environment.